Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Y Holoye

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
JAMA|August 5, 1983
The tumor lysis syndromeM A Baumann, J C Frick, P Y Holoye
Cancer Treatment Reports|November 1, 1976
Pulmonary toxicity in long-term administration of BCNUP Y Holoye, D E Jenkins, S D Greenberg
Cancer Chemotherapy Reports|May 1, 1975
Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasiaM L Samuels, D E Johnson, P Y Holoye
Cancer|August 1, 1975
Bleomycin combination chemotherapy in the management of testicular neoplasiaM L Samuels, P Y Holoye, D E Johnson
American Journal of Clinical Oncology|December 1, 1989
Phase II study of idarubicin in extensive-disease non-small-cell lung cancerT Umsawasdi, P Y Holoye, D Jeffries, et al.
Cancer|December 1, 1977
Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassayA Broughton, J E Strong, P Y Holoye, et al.
Annals of Internal Medicine|January 1, 1978
Bleomycin hypersensitivity pneumonitisP Y Holoye, M A Luna, B MacKay, et al.
Cancer|July 1, 1978
Chemoimmunotherapy of small cell bronchogenic carcinomaP Y Holoye, M L Samuels, T Smith, et al.
American Journal of Clinical Oncology|October 1, 1983
Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lungR Komaki, J D Cox, P Y Holoye, et al.
Cancer Chemotherapy Reports|November 1, 1975
Combination vincristine (NSC-67574) and hydroxyurea (NSC-32065) for metastatic renal carcinomaD E Johnson, L Rodriguez, P Y Holoye, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
JAMA|August 5, 1983
The tumor lysis syndromeM A Baumann, J C Frick, P Y Holoye
Cancer Treatment Reports|November 1, 1976
Pulmonary toxicity in long-term administration of BCNUP Y Holoye, D E Jenkins, S D Greenberg
Cancer Chemotherapy Reports|May 1, 1975
Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasiaM L Samuels, D E Johnson, P Y Holoye
Cancer|August 1, 1975
Bleomycin combination chemotherapy in the management of testicular neoplasiaM L Samuels, P Y Holoye, D E Johnson
American Journal of Clinical Oncology|December 1, 1989
Phase II study of idarubicin in extensive-disease non-small-cell lung cancerT Umsawasdi, P Y Holoye, D Jeffries, et al.
Cancer|December 1, 1977
Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassayA Broughton, J E Strong, P Y Holoye, et al.
Annals of Internal Medicine|January 1, 1978
Bleomycin hypersensitivity pneumonitisP Y Holoye, M A Luna, B MacKay, et al.
Cancer|July 1, 1978
Chemoimmunotherapy of small cell bronchogenic carcinomaP Y Holoye, M L Samuels, T Smith, et al.
American Journal of Clinical Oncology|October 1, 1983
Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lungR Komaki, J D Cox, P Y Holoye, et al.
Cancer Chemotherapy Reports|November 1, 1975
Combination vincristine (NSC-67574) and hydroxyurea (NSC-32065) for metastatic renal carcinomaD E Johnson, L Rodriguez, P Y Holoye, et al.
Pageof 6